Evidence map›Paper›PMID 35174801›Full record

Trial reportRetina (Philadelphia, Pa.)2022

VALIDATION OF A DEEP LEARNING-BASED ALGORITHM FOR SEGMENTATION OF THE ELLIPSOID ZONE ON OPTICAL COHERENCE TOMOGRAPHY IMAGES OF AN USH2A-RELATED RETINAL DEGENERATION CLINICAL TRIAL.

Jessica Loo, Glenn J Jaffe, Jacque L Duncan, David G Birch, Sina Farsiu

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Retina (Philadelphia, Pa.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03146078 (Rate of Progression in USH2A-related Retinal Degeneration), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03146078 active not recruitingnot on this map

Rate of Progression in USH2A-related Retinal Degeneration

TypeobservationalSponsorJaeb Center for Health ResearchRan2017 to 2029Enrolled127ConditionsUsher Syndrome, Type 2A, Retinitis Pigmentosa 39
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Artificial intelligence applications in inherited retinal dystrophies.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Artificial intelligence in retinal disease: clinical application, challenges, and future directions.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Jessica LooDepartment of Biomedical Engineering, Duke University, Durham, North Carolina.
Glenn J JaffeDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
Jacque L DuncanDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California; and.
David G BirchRetina Foundation of the Southwest, Dallas, Texas.
Sina FarsiuDepartment of Biomedical Engineering, Duke University, Durham, North Carolina.
Duke University · USDuke Medical Center · USRetina Foundation of the Southwest · USUniversity of California, San Francisco · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
MEASURES OF HUMAN RECEPTOR AND POST RECEPTOR ACTIVITYR01EY009076 · NEI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BIRCH, DAVID G, HOOD, DONALD C. · 1991 to 2021
$8.3M
NEI NIH HHS P30 EY005722NEI NIH HHS R01 EY009076
6 · The paper itself

Abstract

purposeTo assess the generalizability of a deep learning-based algorithm to segment the ellipsoid zone (EZ).

methodsThe dataset consisted of 127 spectral-domain optical coherence tomography volumes from eyes of participants with USH2A-related retinal degeneration enrolled in the RUSH2A clinical trial (NCT03146078). The EZ was segmented manually by trained readers and automatically by deep OCT atrophy detection, a deep learning-based algorithm originally developed for macular telangiectasia Type 2. Performance was evaluated using the Dice similarity coefficient between the segmentations, and the absolute difference and Pearson's correlation of measurements of interest obtained from the segmentations.

resultsWith deep OCT atrophy detection, the average (mean ± SD, median) Dice similarity coefficient was 0.79 ± 0.27, 0.90. The average absolute difference in total EZ area was 0.62 ± 1.41, 0.22 mm2 with a correlation of 0.97. The average absolute difference in the maximum EZ length was 222 ± 288, 126 µm with a correlation of 0.97.

conclusionDeep OCT atrophy detection segmented EZ in USH2A-related retinal degeneration with good performance. The algorithm is potentially generalizable to other diseases and other biomarkers of interest as well, which is an important aspect of clinical applicability.

Indexed as

Deep LearningRetinal DegenerationAlgorithmsAtrophyExtracellular Matrix ProteinsHumansTomography, Optical CoherenceVisual AcuityExtracellular Matrix ProteinsUSH2A protein, human

Identifiers

PMID35174801
PMCPMC9232868
OpenAlexW4212902813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.